Cubist Systematic Strategies, LLC Black Diamond Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$2.67 - $5.74 $76,845 - $165,202
28,781 Added 192.93%
43,699 $221,000
Q4 2023

Feb 14, 2024
BUY
$1.77 - $3.03 $26,404 - $45,201
14,918 New
14,918 $41,000
Q2 2023

Aug 14, 2023
BUY
$1.43 - $6.18 $33,190 - $143,437
23,210 New
23,210 $117,000
Q3 2022

Nov 14, 2022
BUY
$1.68 - $4.01 $283 - $677
169 Added 1.07%
15,973 $27,000
Q2 2022

Aug 15, 2022
BUY
$1.5 - $3.63 $4,866 - $11,775
3,244 Added 25.83%
15,804 $39,000
Q1 2022

May 16, 2022
SELL
$2.66 - $5.61 $52,255 - $110,208
-19,645 Reduced 61.0%
12,560 $35,000
Q4 2021

Feb 14, 2022
BUY
$5.18 - $8.48 $29,355 - $48,056
5,667 Added 21.35%
32,205 $172,000
Q3 2021

Nov 15, 2021
SELL
$8.46 - $12.42 $562,116 - $825,234
-66,444 Reduced 71.46%
26,538 $225,000
Q2 2021

Aug 16, 2021
BUY
$12.19 - $28.17 $883,689 - $2.04 Million
72,493 Added 353.81%
92,982 $1.13 Million
Q1 2021

May 17, 2021
BUY
$22.23 - $34.75 $31,699 - $49,553
1,426 Added 7.48%
20,489 $497,000
Q4 2020

Feb 16, 2021
BUY
$29.47 - $35.0 $561,786 - $667,205
19,063 New
19,063 $611,000
Q3 2020

Nov 16, 2020
SELL
$26.17 - $43.07 $143,280 - $235,808
-5,475 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$22.3 - $44.8 $122,092 - $245,279
5,475 New
5,475 $231,000

Others Institutions Holding BDTX

# of Institutions
117
Shares Held
48.8M
Call Options Held
1.84M
Put Options Held
1.93M
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $79.2M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email